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Very long chain fatty acids (VLCFAs) are essential
fatty acids with multiple functions, including cer-
amide synthesis. Although the components of the
VLCFA biosynthetic machinery have been eluci-
dated, how their activity is regulated to meet the
cell’s metabolic demand remains unknown. The
goal of this study was to identify mechanisms
that regulate the rate of VLCFA synthesis, and we
discovered that the fatty acid elongase Elo2 is
regulated by phosphorylation. Elo2 phosphorylation
is induced upon inhibition of TORC1 and requires
GSK3. Expression of nonphosphorylatable Elo2
profoundly alters the ceramide spectrum, reflecting
aberrant VLCFA synthesis. Furthermore, VLCFA
depletion results in constitutive activation of auto-
phagy, which requires sphingoid base phosphory-
lation. This constitutive activation of autophagy
diminishes cell survival, indicating that VLCFAs
serve to dampen the amplitude of autophagy.
Together, our data reveal a function for TORC1
and GSK3 in the regulation of VLCFA synthesis
that has important implications for autophagy and
cell homeostasis.
INTRODUCTION
Cells have developed mechanisms that sense environmental al-
terations and generate responses that maintain cellular homeo-
stasis. A major challenge to homeostasis is nutrient availability.
Cells detect changes in nutrient availability and activate signal
transduction pathways that produce an integrated response1036 Cell Reports 5, 1036–1046, November 27, 2013 ª2013 The Autthat rewires cell metabolism and mobilizes new energy sources
(De Virgilio and Loewith, 2006).
The kinase Target of Rapamycin (TOR) plays a central role in
the cellular nutrient response. Two TOR homologs have been
identified in Saccharomyces cerevisiae, Tor1 and Tor2 (Kunz
et al., 1993), which associate with several proteins to form two
distinct functional complexes: TOR complex 1 (TORC1) and
TORC2. TORC2 is insensitive to rapamycin and contains Tor2,
Avo1, Avo2, Avo3, Bit61, and Lst8. Relatively little is known
about TORC2, except that it controls the actin cytoskeleton
and sphingolipid biosynthesis (Aronova et al., 2008; Cybulski
and Hall, 2009; Tabuchi et al., 2006). The rapamycin-sensitive
TORC1, which consists of Kog1, Lst8, Tco89, and Tor1 or Tor2
(Loewith et al., 2002), strongly depends on nutrient availability,
in particular nitrogen (Barbet et al., 1996). Under nutrient-rich
conditions, TORC1 promotes growth-related processes like pro-
tein synthesis, ribosome biogenesis, and tRNA synthesis, while
inhibiting catabolic processes like autophagy (De Virgilio and
Loewith, 2006).
Macroautophagy (here referred to as autophagy) is a major
cellular response triggered by multiple stimuli (He and Klionsky,
2009). It involves the delivery of cytoplasmic components to the
yeast vacuole for degradation, thereby generating an internal
pool of molecules that can be used for metabolism. TORC1 in-
hibits autophagy when nutrient levels are sufficient. However,
under conditions of low nutrient availability, TORC1 activity is
downregulated, leading to induction of autophagy (Noda and
Ohsumi, 1998). Rapamycin treatment mimics nitrogen depletion
and induces autophagy even in the presence of nutrients (Noda
and Ohsumi, 1998).
Under nutrient-rich conditions, TORC1 inhibits autophagy by
phosphorylating Atg13, thereby preventing its association with
the kinase Atg1 (Kamada et al., 2000). Under conditions of low
nutrient availability, downregulation of TORC1 leads to dephos-
phorylation of Atg13, causing it to bind and activate Atg1. Atg1hors
then induces formation of the autophagosome at the phago-
phore assembly site (He and Klionsky, 2009).
In mammalian cells, autophagy can also be activated by phos-
phorylated sphingosine, potentially through downregulation of
TORC1, but the mechanism remains poorly defined (Lavieu
et al., 2006; Young et al., 2013). Sphingoid bases, also known
as long chain bases (LCBs), are best known as backbones of
ceramides. Ceramides, which are structural constituents of eu-
karyotic membranes, also contain a VLCFA in addition to the
LCB backbone. The LCBs in yeast are sphinganine (dihydros-
phingosine [DHS]) and 4OH-sphinganine (phytosphingosine
[PHS]). LCBs are synthesized by condensing palmitoyl-CoA
with serine by serine palmitoyltransferase (SPT) to form 3-keto-
sphinganine, which is subsequently converted into DHS by
Tsc10 and then hydroxylated by Sur2 to form PHS (Figure S1A).
LCBs can be phosphorylated by Lcb4 and to a lesser extent by
Lcb5 (Nagiec et al., 1998), and LCBs and phosphorylated LCBs
(LCBPs) are signaling molecules (Dickson, 2008). PHS and DHS
can be condensed with very long chain acyl-CoA by ceramide
synthase to form dihydroceramide and phytoceramide, which
are further processed to yield more complex sphingolipids.
Sphingolipid synthesis is carefully regulated by the cell, and a
correct balance of LCBs, VLCFAs, and ceramide is crucial for
cell viability (Kobayashi and Nagiec, 2003). The activity of SPT
is one of the control points in sphingolipid synthesis, and several
recent publications have identified Orm1 and Orm2 as targets of
a feedback mechanism that regulates SPT (Breslow et al., 2010;
Han et al., 2010). When LCB levels are sufficiently high, unphos-
phorylated Orm1/2 bind and inhibit SPT. However, when sphin-
golipid levels are low, the adaptor proteins Slm1 and Slm2 recruit
the kinases Ypk1 and Ypk2 to a TORC2-containing plasma
membrane compartment, where they are phosphorylated and
activated by TORC2 and Pkh1/2 kinases (Berchtold et al.,
2012; Niles et al., 2012). Ypk1/2 subsequently phosphorylates
Orm1/2, relieving their inhibition of SPT, which synthesizes
LCBs (Berchtold et al., 2012; Roelants et al., 2011).
The rate of LCB synthesis is strongly affected by the supply of
VLCFAs; a low rate of VLCFA synthesis leads to accumulation
of LCBs, which is detrimental to cell survival (Kobayashi and
Nagiec, 2003). VLCFA synthesis takes place at the endoplasmic
reticulum (ER) in a four-step biochemical cycle (Figure S1A; Nug-
teren, 1965): First, malonyl-CoA is condensed with an acyl-CoA
precursor; the resulting 3-keto intermediate is then reduced; the
3-hydroxy species is dehydrated; and finally the enoyl product is
reduced to yield a saturated fatty acid (FA) chain that is two
carbons longer than its precursor. This cycle is repeated several
times to yield C22, C24, and C26 FAs, which are the most prev-
alent yeast VLCFAs. The length of the carbon chain is deter-
mined by the FA elongase proteins (Elops) Elo2 and Elo3 (Denic
and Weissman, 2007; Oh et al., 1997).
Surprisingly, while significant progress has beenmade in eluci-
dating the mechanisms that regulate LCB synthesis, it remains
unknown how the rate of VLCFA synthesis is controlled. In addi-
tion, although defects in VLCFA synthesis result in elevated LCB
levels that lead to reduced cell survival (Kobayashi and Nagiec,
2003), the underlying cause of this survival defect remains
unclear. In this study, we describe a molecular mechanism that
regulates VLCFA synthesis to maintain cellular homeostasis.Cell ReRESULTS
Phosphorylation of Elo2 Is Important for its Activity
The molecular mechanisms that regulate fatty acid elongation
remain unknown. To gain insight into regulation of the FA elon-
gation cycle, we systematically searched for posttranslational
modifications of proteins involved in this process using mass
spectrometry (MS). Interestingly, we found that Elo2 was phos-
phorylated on three conserved residues in its C terminus, i.e.,
T334, S336, and S338 (Figures 1A, 1B, S1B, and S1C). Elo2
homologs in S. pombe, humans, and mice have also been found
to be phosphorylated on corresponding residues in phospho-
proteomic studies (Daub et al., 2008; Ville´n et al., 2007; Wil-
son-Grady et al., 2008), indicating that Elo2 phosphorylation is
evolutionarily conserved.
To confirm our MS data, we analyzed Elo2 mobility on a Phos-
tag gel (Kinoshita et al., 2006). A slower migrating Elo2 band was
detected that disappeared after l phosphatase treatment,
demonstrating it corresponds to phosphorylated Elo2 (Fig-
ure 1C). Approximately 10% of Elo2 was phosphorylated in log
phase cells under rich growth conditions. No slower migrating
band could be detected in cells expressing the elo23A allele,
which encodes a form of Elo2 in which T334, S336, and S338
are mutated to alanine, showing that Elo2 is phosphorylated on
one or several of these residues (Figure 1D; expression levels
of this mutant were reduced, see below).
To begin analyzing the relevance of Elo2 phosphorylation, we
crossed an elo23A mutant with an elo3D deletion mutant. While
either ELO2 or ELO3 can be deleted individually, the double
mutant is not viable (Revardel et al., 1995). Interestingly, tetrad
analysis showed that approximately 36% of elo23A elo3D dou-
ble-mutant spores were not viable, whereas double mutants
that did form a colony had a very slow growth phenotype (Fig-
ure 1E; data not shown). elo23A elo3D double mutants were
also more sensitive to various types of stress, including heat
stress (Figure S1D). These data indicate that Elo2 phosphoryla-
tion is important for its activity.
Phosphorylation of Elo2 Contributes to Balanced LCB
and Ceramide Synthesis
To gain further insight in the physiological importance of Elo2
phosphorylation, we analyzed the sphingolipid spectrum by
MS (Figure 2; Table S2). In wild-type (WT) cells, ceramides
mostly contained VLCFA moieties with a chain length of 26
carbons (Figure 2A), and complex sphingolipids IPC, MIPC,
and M(IP)2C mainly consisted of a total number of 44 carbons
(Figures 2B–2D). In contrast, elo2D and elo3D single mutants
showed strong reductions in VLCFA chain lengths (Figure 2A).
Interestingly, VLCFA chain lengths in the elo23A mutant were
also reduced, indicating that phosphorylation of Elo2 is impor-
tant for VLCFA synthesis. VLCFA moieties in ceramides were
shortest in the elo23A elo3D double mutant and mainly consisted
of C14 FA chains (Figure 2A). Furthermore, VLCFA chains of
complex sphingolipids in the elo23A elo3D double mutant
were also shorter than in either of the elo23A and elo3D single
mutants (Figures 2B–2D), which supports the idea that Elo2
and Elo3 have partially nonredundant functions in VLCFA syn-
thesis. In addition, the total amounts of ceramides and complexports 5, 1036–1046, November 27, 2013 ª2013 The Authors 1037
Figure 1. Phosphorylation of Elo2
(A) Graphical representation of the ER transmembrane protein Elo2.
(B) Elo2 phosphorylation sites are highly conserved.
(C) Elo2 is a phosphoprotein. Elo2-9Myc was immunoprecipitated, incubated with l phosphatase, and analyzed by Phos-tag SDS-PAGE and anti-Myc western
blotting. Numbers below the graph indicate the percentage of phosphorylated Elo2.
(D) Elo23A is not phosphorylated in vivo. Elo2 phosphorylation was analyzed as in (B).
(E) Tetrad dissection of spores derived from an ELO2/elo23A ELO3/elo3D diploid.sphingolipids were generally reduced in the elo2D, elo23A, elo3D
single mutants as well as in the elo23A elo3D double mutant
(Table S2), which is in accordance with a previous study that
analyzed sphingolipid levels in elo2D and elo3D mutants (Ejsing
et al., 2009). Because the total amounts of lipids were highly
reduced (particularly the C44:0 species in elo2D and elo23A mu-
tants; Figures 2C and 2D), the relative contribution of otherwise
minor abundant lipids such as C46:0 appeared to be increased,
even though their absolute levels were strongly reduced in com-
parison with WT cells (Table S2). These data indicate that phos-
phorylation of Elo2 also affects the flux by which different lipids
are synthesized.
Finally, we analyzed cellular phospholipid content and
found that while phospholipid composition was unaffected (Fig-
ure S2A), mutations in ELO2 and ELO3 resulted in altered acyl
chain composition (Table S2). Together, our data demonstrate
that Elo2 phosphorylation contributes to maintaining the cellular
sphingolipid balance and the elo23A phenotype is intermediate
between the WT and null alleles.
Reducing the Synthesis of LCBs and LCBPs Promotes
Survival of elo23A elo3DMutants
It has previously been shown that reduced VLCA synthesis
results in imbalances in LCB levels, which are toxic to cells
(Kobayashi and Nagiec, 2003). To gain insight into the possible
effect of Elo2 phosphorylation on LCB levels, we directly
analyzed free LCBs. Interestingly, elo23A and elo3D single
mutants, but particularly elo23A elo3D double mutants, all had
increased levels of free LCBs (Figure 3A; Table S3). These1038 Cell Reports 5, 1036–1046, November 27, 2013 ª2013 The Autmutants also showed strongly increased levels of LCBPs (Fig-
ure 3B), indicating that Elo2 phosphorylation prevents accumu-
lation of LCBs and LCBPs.
Based on these findings, we speculated that the slow-growth
phenotype of the elo23A elo3D double mutant might be caused
by LCB accumulation. Indeed, low doses of myriocin (an antibi-
otic that inhibits SPT, the first step in LCB production) substan-
tially improved growth of the elo23A elo3D double mutant
(Figure 3C), which was at least in part due to increased cell sur-
vival (Figure S2B). Consistently, expression of lcb1-C180W, a
dominant-negative allele of LCB1 that moderately inhibits SPT
activity (Gable et al., 2002), also improved growth and survival
of this mutant (Figures S2C and 2D). These data support the
hypothesis that defects in VLCFA synthesis result in unbalanced
LCB synthesis, impairing cell survival.
Because reducing the rate of LCB synthesis improved
growth and survival of elo23A elo3D mutants, we predicted that
increasing the rate of LCB synthesis should have the opposite
effect. Deletion of ORM2 has previously been shown to increase
LCB synthesis by SPT (Breslow et al., 2010; Han et al., 2010).
Accordingly, although elo23A orm2D and elo3D orm2D double
mutants were viable (Figure 3D), an elo23A elo3D orm2D triple
mutant was only viable when cells contained a plasmid harboring
ORM2 (Figure 3E). Thus, increasing the activity of SPT by dele-
tion of ORM2 promotes cell death of elo23A elo3D mutants.
The phosphorylation state of the Orm proteins is under feed-
back regulation by downstream intermediates in the sphingolipid
synthesis pathway (Breslow et al., 2010; Liu et al., 2012). When
LCB levels are low, for example after myriocin treatment, Orm1hors
Figure 2. Phosphorylation of Elo2 Is Impor-
tant for Elo2 Activity
(A) Accumulation of ceramide species with short-
ened fatty acyl moieties in elo2 and elo3Dmutants.
Data are presented as mol% of total ceramides
and organized by fatty-acyl chain lengths.
(B–D) Preventing Elo2 phosphorylation leads to
accumulation of ceramides with short-chain fatty
acyl chains. Complex sphingolipids are repre-
sented as the sum of the number of carbons of the
sphingoid base and the fatty acid, and data are
presented asmol% of each lipid class, i.e., IPC (B),
MIPC (C), andM(IP)2C (D). Average values of three
independent biological replicates are shown; error
bars represent SD (note that due to experimental
variation between each experiment, the total value
of lipids may appear to exceed 100%; for data of
individual experiments, see Table S2).becomes hyperphosphorylated, thereby relieving inhibition of
SPT (Breslow et al., 2010; Liu et al., 2012). We have previously
shown that multiple forms of Orm1 exist in the cell (unphosphory-
lated, hypophosphorylated, andhyperphosphorylatedOrm1) and
that myriocin primarily induces hyperphosphorylation (Liu et al.,
2012). Consistent with our previous findings, approximately 8%
of the Orm1 population was hyperphosphorylated under basal
conditions in WT cells, which increased to 78% after treatment
with myriocin (Figure 3F). In contrast, under basal conditions, no
hyperphosphorylatedOrm1 could be detected in elo23Amutants.
Furthermore, myriocin treatment resulted in much lower levels of
hyperphosphorylated Orm1 (42%) in elo23A mutants than in WT
cells. Myriocin-induced Orm1 hyperphosphorylation did not
occur at all in either elo3D single mutants or in elo23A elo3D
double mutants (Figure 3F). These data indicate that preventing
Elo2 phosphorylation reduces the activity of signaling pathways
that target Orm1p,most likely as a result of accumulation of inter-
mediates in the sphingolipid synthesis pathway.
LCBs are mainly phosphorylated by Lcb4 (Nagiec et al., 1998).
Because accumulation of LCBPs is particularly toxic to cells (Kim
et al., 2000), we tested the effect of preventing LCB phosphory-
lation on growth of elo23A elo3D double mutants. Interestingly,
deletion of LCB4 improved growth of elo23A elo3D mutants
(Figure 3G). Conversely, deletion of DPL1, which encodes the
major enzyme that degrades LCBPs (Saba et al., 1997), caused
reduced growth of elo23Amutant cells (Figure S2E) and synthetic
lethality in an elo3D background (J.M.E., unpublished data;
Aguilar et al., 2010).
Taken together, these data indicate that Elo2 is regulated
by phosphorylation and that accumulation of LCBs and LCBPs
impairs survival of elo23A elo3D double mutants.
Reduced VLCFA Synthesis Activates Autophagy in an
LCBP-Dependent Manner
What causes the strongly reduced cell growth and survival
of elo23A elo3D mutants? Previously, we found that inhibitionCell Reports 5, 1036–1046, Noof FA synthase induces a starvation
response (Pultz et al., 2012). A major
aspect of this response is autophagy(Kamada et al., 2000). Thus, we hypothesized that autophagy
might be activated in elo23A elo3D mutants. We studied auto-
phagy by monitoring the behavior of the GFP-Atg8 reporter un-
der the control of the ATG8 promoter (He and Klionsky, 2009).
First, we examined the localization of GFP-Atg8 to the vacu-
ole, a commonly used autophagy assay (Cheong and Klionsky,
2008). When grown in media containing nitrogen, the GFP-
Atg8 signal was primarily diffuse and cytoplasmic both in WT
cells and in elo23A single mutants, while vacuolar staining could
be detected in approximately 8%of the cells, which increased to
approximately 78% upon nitrogen starvation (Figure 4A). Inter-
estingly, the number of autophagic cells was significantly higher
in the elo3D mutant (Figure 4A); moreover, elo23A elo3D double
mutants showed a synergistic increase in the percentage of
autophagic cells (62%), showing that combined activity of Elo2
and Elo3 is required to suppress autophagy under nitrogen-
rich conditions. During nitrogen starvation, the number of auto-
phagic elo23A elo3D double mutant cells was also significantly
higher than WT cells. As expected, autophagy in these mutants
was entirely dependent on ATG1 and ATG7 (Figure 4B; C.Z.,
unpublished data).
We also monitored autophagic flux, which is the vacuolar
transfer and degradation of autophagosomes over time, using
a GFP-Atg8 processing assay (Cheong and Klionsky, 2008).
This assay exploits the fact that part of the Atg8 pool is present
in the interior of autophagosomes, and this pool is transported
into the vacuole lumen. Vacuolar hydrolases cleave the GFP-
Atg8 fusion protein to release free GFP, which has a relatively
long half-life in the vacuole interior and which can be detected
bywestern blotting. Interestingly, even under nutrient-rich condi-
tions, autophagic flux was approximately four times higher in the
elo23A elo3D double mutant than in WT cells (compare lanes 1
and 10 in Figure S3A; quantified in Figure S3B), which is consis-
tent with our GFP-Atg8 localization data. We conclude that the
autophagic flux in elo23A elo3D double-mutant cells is increased
even under nutrient-rich conditions.vember 27, 2013 ª2013 The Authors 1039
Figure 3. Accumulation of LCBs in elo2 and
elo3 Mutants Impairs Cell Viability
(A and B) Accumulation of LCBs and LCBPs in elo2
and elo3D mutants. LCBs (A) and LCBPs (B) were
detected by liquid chromatography MS. Data are
normalized to the levels observed in WT cells.
(C) Slow growth of elo23A elo3D mutants can be
rescued by low doses of myriocin.
(D and E) Synthetic lethal phenotype of the elo23A
elo3D orm2D mutant. Spot assays of WT, orm2D
single mutants, and elo23A orm2D and elo3D
orm2D double mutants (D). Plasmid shuffle with
elo23A elo3D orm2D triple-mutant cells harboring
an URA3-based plasmid containing ORM2 shows
inviability on 5-FOA (E). WT control: strain
RDKY3023, which is ura.
(F) Diminished myriocin-induced Orm1 phosphor-
ylation in elo23A mutant cells. Strains were
treated with myriocin and Orm1 phosphory-
lation was analyzed by western blotting. pp-
Orm1, hyperphosphorylated Orm1; p-Orm1,
hypophosphorylated Orm1; and Orm1, un-
phosphorylated Orm1.
(G) Deleting LCB4 improves the growth of elo23A
elo3D double mutants.Autophagy was also monitored by following the vacuolar
localization of aminopeptidase I (Ape1). Ape1 is selectively trans-
ported into the vacuole via the cytoplasm-to-vacuole targeting
pathway under vegetative conditions and via autophagy under
starvation conditions (Baba et al., 1997). GFP-Ape1 was present
in cytoplasmic foci in approximately 70% of the WT cells, while
30% of the cells had vacuolar GFP-Ape1 (Figure S3C). The
pattern of GFP-Ape1 localization in elo23A single-mutant cells
was similar to WT cells. In contrast, GFP-Ape1 localized to the
vacuole in approximately 70% of the elo3D single mutants and
in 97% of the elo23A elo3D double-mutant cells (Figure S3C).
These data show that reduced VLCFA synthesis triggers
autophagy.
To determine whether constitutive activation of autophagy
underlies the slow-growth phenotype of elo23A elo3D double
mutants, we deletedATG1 in this genetic background. Strikingly,
deletion of ATG1 considerably improved growth of both the
elo3D single mutant and the elo23A elo3D double mutant (Fig-
ure 4C). Similar results were obtained when we deleted ATG7
(Figure 4D). Thus, the strong growth defect of elo23A elo3D
mutant is at least in part caused by constitutive autophagy.
If excessive autophagy indeed causes reduced survival of
elo23A elo3D mutants, then deletion of SCH9, which encodes a
kinase that inhibits autophagy (Yorimitsu et al., 2007), should
result in an aggravated growth phenotype. Indeed, deletion of1040 Cell Reports 5, 1036–1046, November 27, 2013 ª2013 The AuthorsSCH9 reduced growth of both elo23A
and elo3D singe mutants (Figure S3D),
and we were unable to isolate any
sch9D elo23A elo3D triple mutants by
tetrad dissection (not shown). A limitation
of tetrad dissection is that only a relatively
small number of tetrads can be analyzed
simultaneously, in particular because36% of elo23A elo3D double-mutant spores are not viable (Fig-
ure 1E). Therefore, we resorted to bulk segregation analysis
(Michelmore et al., 1991). We randomly isolated spores from
an ELO2/elo23A ELO3/elo3D SCH9/sch9D diploid strain, which
gave rise to 1,164 unique colonies on double selection plates
that contained a combination of nourseothricin and hygromycin
(thus selecting for elo23A elo3D double mutants only). Because
the ELO2, ELO3, and SCH9 loci are not syntenic, the WT
SCH9 allele and the sch9D mutation should segregate in a
Mendelian ratio of 1:1, and therefore half of the 1,164 isolates
should contain the sch9D deletion. However, not one of the
1,164 offspring was sch9D. This strongly implies that SCH9 is
essential for survival of elo23A elo3D cells. One explanation for
these results is that SCH9 is essential for suppressing excessive
autophagy in this mutant.
What is the signal that triggers autophagy? Because we found
that increased LCB and LCBP levels contributed to the reduced
survival of the elo23A elo3D mutant, we hypothesized that LCBs
or LCBPs might activate autophagy. Treatment of WT cells with
increasing doses of exogenous PHS resulted in a significant in-
crease in the number of cells undergoing autophagy (Figure S3E),
indicating that PHS is sufficient to induce autophagy. If accumu-
lation of LCBs is responsible for autophagy in elo23A elo3D
mutants, then treatment with myriocin should inhibit autophagy.
Indeed, autophagy wasmodestly but significantly reduced when
Figure 4. Constitutive Activation of Auto-
phagy Reduces Viability of elo23A elo3D
Double Mutants
(A) Vacuolar localization of GFP-Atg8. Cells were
grown to log phase in SC medium with nitrogen
and either maintained in SC with nitrogen
(‘‘+ Nitrogen’’) or transferred to SC without nitro-
gen for 3 hr (‘‘ Nitrogen’’), after which GFP-Atg8
localization was quantified by fluorescence
microscopy.
(B) ATG1 and ATG7 are required for autophagy
in elo mutants. Cells were grown to log phase
in synthetic medium with nitrogen and analyzed
as in (A).
(C and D) Preventing autophagy by deleting ATG1
(C) or ATG7 (D) promotes survival of elo23A elo3D
mutants.
(E) Deletion of LCB4 suppresses autophagy in
elo23A elo3D mutants. Autophagy was measured
as in (A).
Error bars indicate SD. Numbers indicate p values
(Student’s t test).cells were grown in the presence of 1 mM myriocin (Figure S3F).
This dose of myriocin is not sufficient to fully inhibit SPT, but
higher doses could not be tested due to severe impairment of
cell survival, which confounded the results (Figure S2B; C.Z., un-
published data). We also analyzed autophagy in strains trans-
formed with an empty vector or with plasmids containing either
WT LCB1 or dominant-negative lcb1-C180W (both under control
of the LCB1 promoter). Interestingly, providing additional copies
of LCB1 significantly increased autophagy in the elo23A elo3D
mutant, while expression of the lcb1-C180W allele resulted in
decreased autophagy (Figure S3G).
Finally, we studied the effect of Lcb4 on autophagy, because
deletion of LCB4 improved the growth of the elo23A elo3D
mutant (Figure 3G). Strikingly, deletion of LCB4, but not LCB5,
strongly reduced autophagy in elo3D and elo23A elo3D mutants
(Figure 4E; data not shown). Conversely, deletion of DPL1 signif-
icantly increased autophagy in elo23A single-mutant cells (Fig-
ure S3H). These data strongly suggest that LCBs and LCBPs
promote autophagy in elo mutants.
Together, these data show that (1) autophagy is constitutively
active in mutants with defects in VLCFA synthesis, (2) phos-
phorylation of Elo2 helps prevent excessive activation of the
autophagy pathway, (3) constitutive activation of autophagy isCell Reports 5, 1036–1046, Nodetrimental to survival of these mutants,
and (4) cells may sense LCBPs as a proxy
for VLCFA levels to activate autophagy.
Elo2 Phosphorylation Requires
GSK3 and Is Inhibited by TORC1
Serendipitously, during sample prepara-
tion, we observed that Elo2 phosphoryla-
tion appeared to be increased when Elo2
was isolated from nutrient-depleted cells
compared with cells grown in rich
medium. Intrigued by this observation,
we tested whether Elo2 phosphorylationresponds to nutrient availability. Indeed, nitrogen depletion sub-
stantially increased Elo2 phosphorylation compared with cells
grown in YPD (62% versus 12%; Figure 5A; see Figure S4A for
loading controls). Phosphorylation of Elo2 was also increased
after treatment with the TORC1 inhibitor rapamycin (78%). In
contrast, neither FK506, which inhibits the phosphatase calci-
neurin, nor PHS had a strong effect on Elo2 phosphorylation.
These data suggest that TORC1 inhibits Elo2 phosphorylation
under nutrient-rich conditions.
The phosphorylated residues in Elo2 are all followed by pro-
lines, indicating that a proline-directed kinase phosphorylates
Elo2. We therefore screened all proline-directed kinases
(MAPKs, CDKs, Yak1, andKns1) for an involvement in Elo2 phos-
phorylation. However, Elo2 phosphorylation was unaffected in
mutants lacking any of these kinases (Figures S4B–S4D).
iGPS software (Song et al., 2012) predicted with high confi-
dence that all three Elo2 phosphorylation sites resemble GSK3
consensus sites. Indeed, Elo2 phosphorylation was undetect-
able in a ygk3D mck1D rim11D mrk1D quadruple mutant (from
hereon referred to as gsk3D), which lacks all four GSK3 kinases
found in yeast (Figures 5B and 5C; see Figure S4E for loading
controls), demonstrating that GSK3 regulates Elo2 phosphoryla-
tion in vivo. Consistent with this, overexpression of MCK1 andvember 27, 2013 ª2013 The Authors 1041
Figure 5. Elo2 Phosphorylation Is Positively Regulated by GSK3 and Negatively by TORC1
(A) Elo2 phosphorylation increases after nitrogen starvation and rapamycin treatment. Cells expressing Elo2-9Myc were grown to log phase in YPD and either
transferred to SC-N for 3 hr or treated with 1 mM FK506, 1 mM rapamycin, or 25 mg/ml PHS for 1 hr. Elo2 phosphorylation was analyzed as in Figure 1C. Numbers
below the graph indicate the percentage of phosphorylated Elo2. All samples were obtained from the same experiment but analyzed on two separate gels
(indicated by dividing line).
(B) Elo2 phosphorylation depends on GSK3. Elo2 phosphorylation was analyzed in either WT cells or a mutant lacking all four GSK3 kinases. Numbers below the
graph indicate the percentage of phosphorylated Elo2. The western blot showing Elo2 in the gsk3D strain had to be exposed longer due to reduced Elo2 levels.
(C) Rapamycin-induced Elo2 phosphorylation requires GSK3. WT cells and a mutant lacking all four GSK3 kinases were treated with 1 mM rapamycin for 1 hr and
Elo2 phosphorylation was analyzed as described in Figure 1C. Numbers below the graph indicate the percentage of phosphorylated Elo2. The western blot
showing Elo2 in the mutant strain was exposed longer due to reduced Elo2 levels in this mutant. Arrowheads indicate phosphorylated Elo2 (Elo2 immunopre-
cipitation samples often contain lipids that slightly distort Phos-tag gels).
(D) Reduced Elo2 expression levels in gsk3Dmutants. Strains expressing Elo2-9Myc were grown to log phase and Elo2 levels were analyzed using conventional
SDS-PAGE.
(E) Unphosphorylatable Elo2 is an unstable protein. Log phase ELO2-9MYC and elo23A-9MYC cultures were treated with cycloheximide (CHX) for the indicated
times, and Elo2 stability was analyzed as in (D).
(F) Elo23A protein levels are partially restored by inhibiting the proteasome. Log phase cells were treatedMG132 and Elo2 phosphorylation was analyzed as in (D).
(G) elo23A and elo3Dmutants are sensitized to rapamycin-induced autophagy. Log phase cells were treatedwith 0, 100, or 200 nM rapamycin for 3 hr. The fraction
of cells with vacuolar GFP-Atg8 was analyzed by fluorescence microscopy.
(H) gsk3D mutants are sensitized to autophagy. Autophagy was induced and analyzed as described in (G).MRK1 induced hyperphosphorylation of Elo2 (data not shown).
We screened single-deletion mutants lacking each of the four
GSK3 isoforms and found that MCK1 is responsible for most
of the Elo2 phosphorylation (Figure S4F). A low level of Elo2
phosphorylation still occurred in an mck1D mutant, indicating
that other GSK3 isoforms make minor contributions to Elo2
phosphorylation (Figure S4G). Some Elo2 phosphorylation could
also be detected in a mck1 ygk3 mrk1 triple mutant, whereas
additional deletion of RIM11 in this background resulted in loss
of Elo2 phosphorylation and strongly reduced Elo2 levels (Fig-
ure S4H and see below).1042 Cell Reports 5, 1036–1046, November 27, 2013 ª2013 The AutFinally, since at least some of the effects of TORC1 are medi-
ated by the PP2A-like phosphatase Sit4 (Broach, 2012), we
determined whether Sit4 is involved in regulation of Elo2 phos-
phorylation. Interestingly, whereas 11% of Elo2 was phosphory-
lated under basal conditions in WT cells, deletion of SIT4
reduced Elo2 phosphorylation to just 1% (Figure S4I). Further-
more, rapamycin-induced Elo2 phosphorylation was substan-
tially lower in sit4D mutants than in WT cells (49% versus
92%). These data indicate that Sit4 promotes Elo2 phosphoryla-
tion. In contrast, simultaneous deletion of PPH21 and PPH22,
which encode PP2A phosphatases that have TORC1-dependenthors
Figure 6. Model of the Findings in This Study
Blue indicates metabolic intermediates. See text for details.and independent functions (Broach, 2012), resulted in increased
Elo2 phosphorylation under basal conditions (Figure S4I), sug-
gesting that these phosphatases may dephosphorylate Elo2.
Collectively, although the exact molecular mechanism re-
mains to be determined, these data indicate that Sit4 and
GSK3 promote Elo2 phosphorylation, whereas Pph21/22 may
directly dephosphorylate Elo2.
Phosphorylation of Elo2 May Affect Protein Stability
Howdoes phosphorylation affect Elo2 function? The ER localiza-
tion of unphosphorylatable Elo23A was unaltered, indicating that
phosphorylation does not affect Elo2 localization (Figure S4J).
However, we noticed that Elo2 protein levels were strongly
reduced in the gsk3D mutant compared to WT cells (Figure 5D,
upper panel; Figure S4H). This was specific for Elo2, because
the levels of Pdi1p, another ER-localized protein, were not
affected (Figure 5D, lower panel). The effect of GSK3 on Elo2
stability is likely to be direct, because the levels of nonphosphor-
ylatable Elo23A protein were also strongly reduced (Figure 5E).
Treatment with cycloheximide resulted in further depletion of
Elo23A (Figure 5E), whereas treatment with the proteasome
inhibitor MG132 resulted in partial recovery of Elo23A levels (Fig-
ure 5F). In contrast, Elo2 was not degraded by the autophagy
pathway (Figure S4K). These data show that preventing Elo2
phosphorylation affects its proteasomal turnover.
Elops Dampen the Amplitude of Autophagy
To determine how Elo2 phosphorylation affects autophagy, we
treated cells with low doses of rapamycin to slightly inhibit
TORC1. First, we treated WT cells with increasing concentra-
tions of rapamycin to determine at which dose autophagy is
induced. Increased autophagy was only observed in WT cells
after treatment with at least 200 ng/ml rapamycin (Figure S4L).
However, autophagy was already significantly elevated at
100 ng/ml rapamycin in elo23A and elo3D single mutants and
in elo23A elo3D double mutants (Figure 5G). Consistent with
this, gsk3D mutants were also sensitized to low doses of rapa-
mycin (Figure 5H). Thus, GSK3-dependent phosphorylation of
Elo2 dampens autophagy under conditions of partial TORC1Cell Reinhibition, indicating that VLCFA depletion sensitizes cells to
autophagy.
DISCUSSION
VLCFA synthesis must be carefully regulated, because imbal-
ances in VLCFAs have profound effects on LCB levels and cell
viability (Kobayashi andNagiec, 2003). However, themechanism
whereby cells control the rate of VLCFA synthesis has remained
obscure until this study. Here, we report that VLCFA synthesis is
at least in part dependent on phosphorylation of Elo2. Elo2
phosphorylation was negatively regulated by TORC1 and posi-
tively regulated by GSK3, and Mck1 was the main GSK3 isoform
responsible for Elo2 phosphorylation (see Figure 6 for an over-
view of our findings).
Compared with mammals, very little is known about regulation
of GSK3 kinases in yeast. Mammalian GSK3 is a substrate for
several kinases including ribosomal S6 kinase, a downstream
target of mTORC1 that phosphorylates GSK3 in its N terminus
to inhibit its kinase activity (Zhang et al., 2006). Inhibition of
mammalian GSK3 by the mTOR pathway is consistent with our
finding that GSK3 is a downstream component of the rapamy-
cin-sensitive TORC1 signaling pathway in yeast. Our results
are also consistent with a recent yeast study that found that
TORC1 inhibits Mck1 to regulate tRNA synthesis, although it
remained unknown exactly how TORC1 regulates Mck1 (Lee
et al., 2012).
Completely preventing Elo2 phosphorylation, either by delet-
ing all GSK3 isoforms or by alanine substitution of the phosphor-
ylation sites, resulted in strongly decreased Elo2 levels. This
could be partially rescued with the proteasome inhibitor
MG132, indicating that constitutive dephosphorylation of Elo2
leads to its proteasomal degradation. We do not exclude the
possibility that there may be additional mechanisms by which
phosphorylation regulates Elo2 activity. For instance, it could
affect the composition of the protein complex involved in the
fatty acid elongation cycle. Alternatively, it could regulate Elo2
catalytic activity, for example by regulating access of substrate
to the catalytic site. The exact molecular mechanism by which
Elo2 elongates fatty acids is currently unknown and probably
will remain unknown until the crystal structure of an Elop bound
to its substrate is solved. This structure may also reveal how
phosphorylation of the C terminus affects Elo2 enzymatic
activity.
We found that inhibiting VLCFA synthesis results in a dramatic
loss of viability. It has been reported previously that inhibiting
VLCFA synthesis results in reduced cell viability due to accu-
mulation of LCBs (Kobayashi and Nagiec, 2003), although the
underlying cause was never determined. In this study, we
discovered that this reduced survival was at least partially
caused by LCBP-mediated, constitutive activation of auto-
phagy. Autophagy is a catabolic process aimed at degradation
of cellular components, and while autophagy is well known to
promote cell survival during starvation, it is likely that uncon-
trolled and excessive autophagy will ultimately deplete factors
essential for cell survival.
What could be the physiological function of activation of auto-
phagy by LCBPs in normal cells? Because LCBs and LCBPsports 5, 1036–1046, November 27, 2013 ª2013 The Authors 1043
accumulate when VLCFA levels are low, and because LCBPs
mediate activation of autophagy, we believe that cells may
monitor LCBPs to sense the pool of free FAs. In this model,
depletion of VLCFAs leads to an increase in LCBPs, which
then trigger autophagy, and we speculate that autophagy serves
to replenish cellular FA levels. Interestingly, a recent study
showed that inhibition of TORC1 activates the kinase Npr1,
which in turn phosphorylates and inhibits Orm1/2 to induce
LCB synthesis (Liu et al., 2012; Shimobayashi et al., 2013).
Thus, inhibition of TORC1 may promote ceramide synthesis by
coordinately increasing the production of both VLCFA and
LCBs. This increased ceramide synthesis, which takes place at
the ER, might be important for supplying membrane material
during autophagy. The source of membrane material for auto-
phagy remains subject to debate, although the consensus is
emerging that the ER is a major contributor (Orsi et al., 2010);
therefore, one reason for increased ceramide synthesis could
be to supply the ER with membrane material to sustain the auto-
phagic process.
Although LCBPs are required for induction of autophagy in
elo23A elo3D mutants, we currently do not know the molecular
mechanism by which LCBPs activate autophagy. It is possible
that intracellular receptors exist that induce autophagy upon
binding to LCBPs. However, the yeast proteins that bind LCBs
and LCBPs remain unknown. A recent study identified several
proteins that may bind these lipids in vitro, including Slm1 and
Atg18 (Gallego et al., 2010), but it is unclear whether these
proteins actually bind LCBs and LCBPs in vivo. Alternatively,
LCBPs may activate autophagy through a more indirect mecha-
nism, for example by modulating cellular amino acid levels. We
have indications that elo2D and elo3D mutants indeed have
reduced amino acid pools (N.J.F., unpublished data). Clearly,
additional studies are required to determine how LCBPs activate
autophagy.
In conclusion, we discovered a molecular mechanism for
regulation of VLCFA synthesis that has important implications
for autophagy and cell homeostasis. Because Elo2 phosphoryla-
tion sites are highly conserved and phosphorylation of the
Elo2-related FA elongase ELOVL5 has been observed in phos-
phoproteomic studies of mouse liver and human cell lines
(Daub et al., 2008; Ville´n et al., 2007), the regulatory mechanism
of VLCFA synthesis may be conserved among eukaryotes.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Growth Conditions
S. cerevisiae strains were grown in standard YPD medium unless indicated
otherwise. Strains were directly derived from the S288c strains RDKY3032
and RDKY3615 (Enserink et al., 2009; Flores-Rozas and Kolodner, 1998),
except the gsk3D mutant that was derived from W303, and all strains were
constructed using either standard gene replacement methods or by inter-
crossing (see Table S1 for strains and plasmids).
Analysis of Elo2 Phosphorylation
Elo2was purified as previously described (Denic andWeissman, 2007). Briefly,
50 ml log phase culture was washed with ice-cold water and lysed by bead
beating for 10 min in 2 ml buffer A (50 mM HEPES [pH 6.8], 150 mM KAc,
2 mM MgAc2, 1 mM CaCl2, 200 mM Sorbitol, 1 mM Na3VO4, 10 mM NaF,
and fungal protease inhibitor cocktail, according to themanufacturer’s instruc-
tions; Calbiochem). Lysates were centrifuged for 10min (5,0003 g, 4C), insol-1044 Cell Reports 5, 1036–1046, November 27, 2013 ª2013 The Autuble debris was discarded, and soluble fraction was centrifuged (40 min,
40,000 3 g, 4C) to isolate microsomes. Microsomes were solubilized in
600 ml ice-cold buffer B (buffer A supplemented with 0.5% sodium deoxycho-
late and 0.5% Tergitol/NP-40). Elo2-9Myc was immunoprecipitated with anti-
Myc beads for 2–3 hr at 4C,washed four timeswith 1ml buffer B, and eluted in
Laemmli sample buffer. Elo2 phosphorylation was assessed by Phos-tag
SDS-PAGE (Kinoshita et al., 2006) followed by western blotting with Myc
antibodies.
l Phosphatase Treatments
Elo2-9Myc was purified as described above, washed three times with 1 ml l
buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.5], 1 mM EDTA, 50 mM DTT,
0.01% Tergitol/NP40, and protease inhibitor cocktail) and resuspended in
100 ml l buffer. The samples were split in two, 1.5 ml of l phosphatase
(400,000 U/ml) was added to one of the samples, and both samples were incu-
bated at 30C for 1 hr (vortexed 5 s every 3 min). Elo2 phosphorylation was
analyzed as described above.
Elo2 Stability
Cycloheximide treatment was performed as previously described (Zimmer-
mann et al., 2011). Log phase ELO2-9Myc and elo23A-9Myc strains were
treated with 400 mg/ml cycloheximide for 0, 30, 60, and 120 min.
MG132 treatment was carried out as previously described (Liu et al., 2007).
To permeabilize cells, 0.003% SDS was added for 3 hr to log phase cultures,
after which cells were incubated for 2 hr with 100 mMMG132. Elo2was purified
as described above and analyzed by conventional SDS-PAGE.
Mass Spectrometry
Mapping of phosphorylation sites by MS was carried out as previously
described (Pultz et al., 2012).
Analysis of Orm1 Phosphorylation
Strains harboring an Orm1-HA plasmid (pSH14HA) were grown to mid-log
phase in synthetic medium minus histidine, and myriocin (0.15 mg/ml) was
added for 1 hr. Orm1 phosphorylation was analyzed as previously described
(Liu et al., 2012).
Spot Assays and Plasmid Shuffle
Spot assays were performed as previously described (Kats et al., 2009).
Plasmid shuffle was performed as follows. elo23A elo3D orm2D triple-mutant
cells harboring pBG1805-ORM2 (a URA3-based plasmid containing ORM2
under control of the GAL1 promoter; Gelperin et al., 2005) were grown to log
phase in dropout media lacking uracil and with 2% raffinose and 0.5%
galactose as the carbon source (to express ORM2). Cells were then spotted
on synthetic complete media containing 2% raffinose/0.5% galactose in the
absence or presence of 1 mg/ml 5-fluoroorotic acid (5-FOA) as indicated in
the figure.
Lipid Extraction and Analysis Of Lipid Content
Yeast strains were grown in rich medium until log phase and 25 OD pellets
were harvested. Briefly, glycerophospholipids and sphingolipids were ex-
tracted with pyridine-ethanol-diethylether-water solvent. Sphingolipids were
base-treated withmonomethylamine solvent. Both lipid classes were desalted
with n-butanol and analyzed by electrospray ionization MS as previously
described (Guan et al., 2010). Synthetic internal standards were spiked to
the cell pellets prior to extraction: Cer d18:0/17:0 (0.24 nmol), GlcCer d18:1/
8:0 (4 nmol), C17 sphingosine (3.75 mg), and C17 sphingosine 1-phosphate
(3.75 mg) (Avanti Polar Lipids). The assays were performed with three indepen-
dent biological replicates. LCBs and LCBPs were analyzed as described in
Supplemental Information.
Microscopy
Live cell microscopy was performed as previously described (Enserink et al.,
2006). Cells expressing GFP-Atg8, red fluorescent protein-Atg8, or GFP-
Ape1 were imaged using a Zeiss Axioplan 2 microscope equipped with a
633/1.40 Oil Plan-Apochromat objective (Zeiss), using a charge-coupled
device camera (Zeiss AxioCam Hrc) and AxioVision Rel. 4.6 software (Zeiss),hors
and images were processed using Photoshop and Illustrator software (both
Adobe).
Autophagy Assays
Autophagy was studied using previously described methods (Cheong and
Klionsky, 2008; Shintani and Reggiori, 2008). See Supplemental Information
for details.
Viable Cell Count
Cell viability assays were performed as previously described (Enserink et al.,
2006).
Statistical Methods
All experiments were performed at least three times, and p values were calcu-
lated with the Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2013.10.024.
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